M&A deals shake up Aussie health industry
About this video
Key Points:
Potential upside for Wellness after completing a deal and potential growth due to the Sigma-Chemist Warehouse merger
Observations on current financial market state with suggestions to focus on small cap space
Concerns raised about the automated driving sector, preference for hydrogen engine and discussions on data collection for environmental sustainability
James Whelan, Managing Directior at Barclay Pearce Capital analyses the recent deals in the M&A sector, specifically focusing on the health care sector's move with Sigma (SIG) and Chemist Warehouse. James suggests a potential upside with wellness since they just completed a transaction for wellness, which has been in the market since 2017. Moreover, the merger between Sigma and Chemist Warehouse, an $8.8 billion entity, is set to introduce a super giant in the healthcare sector. James points out that companies aligned with Chemist Warehouse will benefit as products become more accessible overseas, and sales will almost certainly go up.
In discussing the financial market's overall landscape, James outlines that the Dow is hitting all-time highs, suggesting it could be time to be bullish. Nevertheless, he also advises considering the possibility of securing profits, noting that the market now seems fully priced in. The focus shifts to small cap space, with James pointing to potentially profitable companies like Wellness which recently acquired Pain Away.
Lastly, James underlines some concerns with Tesla (TLS) related automation, arguing that automated driving is not a sector he would invest in due to safety concerns. He further mentions that the hydrogen engine could be a more sustainable alternative. Lastly, he touches on the topic of data collection by companies like Commonwealth Bank (CBA), who aim to track customer transaction data to generate an image of customers' carbon footprint, bringing attention to the increasing trend towards green initiatives.
Find the full unedited transcript of this interview below:
0:00
We've seen some major deals in the M&A space recently. Investor reactions being captured in massive moves in these firms share prices. Let's get into some of these moves with James Whelan from Barclays Capital, who joins me in the studio. Hello old friend. Hello old friend. So we've been looking at this health care move with Stigma and Chemist Warehouse huge. But you're looking at a potential upside for well next. Yeah there's some other bits and pieces in there in there as well. First off I'll set the scene. We just completed the transaction for wellness, which has been on the market for a while since about 2017. Formerly is a different name with a chart that probably wouldn't look amazing at it. We've just completed a rights issue with an extra raise on that as well, which is good. That'll get them going to buy pain away. I'll get to that in a second. But the idea also is that they've got a couple of JV products that are with Chemist Warehouse as well. So we're seeing that the alignment that they have with the Sigma Chemist Warehouse now getting bigger. It does it helps. It helps them no end with with what they can have. Also sort of the alignment with Mario I
0:59
just had his name. His name has just gone. But the CEO of Marriott's Mario Tuscany is joining wellness. So he's from Chemist Warehouse. He's joining as chairman of wellness as well. So basically this merger, this $8.8 billion behemoth that's going to become is just changing the landscape for healthcare. It will change the landscape for healthcare it will make. And not to go too much into that deal, because that's not my business at the moment. But the it's it's definitely is changing the idea that that combined entity will just be a super giant. And also the fact that Chemist Warehouse said that they're going to be expanding overseas as well means that anyone who's aligned with Chemist Warehouse, you're going to see those products become much more accessible overseas, and sales will almost certainly go up for those ones, too. So not only will next, but also have a look at some of the other products that are in and aligned with Chemist Warehouse. There could be some good activity on the on the market, especially in the small cap space. Yeah. And is that because some of their marketing expenses and the like also becomes less because they're kind of tied up in this. Yeah. That's right. So you don't have to sell or
1:59
align with two different places. If you're with Sigma and Chemist Warehouse, you've just got one place to do it. It just becomes bigger. This not that. It's a monopoly, but certainly it's better to be aligned with a much bigger entity than it is to be aligned with two mid-sized entities, as this case will see. Yeah, it's going to be a hell of a year ahead in Dave. Well, speaking of that, I mean, we've had fed pivot day. We're seeing the Dow at these record highs. How are you just looking at the overall landscape as we round out 23. Chief volatility is cheap isn't it. What was it last time. The last time the VIX was down here it was four years ago. We've just seen an all time high on the Dow. As much as I want to say it's a time to be bullish it really is. We have been quite significantly bullish. And I've had the tail up going straight into it as best as I can. Uh it's uh I might just want to thin a little bit out going into that in the last couple of days of the year. I know it's not a time when people do a lot of things, but maybe just just shave a little bit off and see what happens in January, because as much of it, it's been priced in, especially with what Powell said this morning, where all of a sudden he's switched from being we're not going to do anything until it goes below
2:59
2% to now sort of basically capitulating. It seemed very strange this morning and the market is now priced that in. And so so what more could the market possibly price in. It's all fully priced if that's the case and maybe lock in a few profits, especially if you happen to be, you know, you have that end of year line that needs to be drawn underneath what it is that you are going to do. Yeah. You get that locked in. Well, I was just talking about the Nasdaq up some 51% over the year. I mean, to the $0.07 to seven. Does it become the I think Scottie tweeted this the other day. Does it become the magnificent 93 next year. And some focus on the other stocks in the I would want I'd probably want to have a little focus on small caps and bringing it back to my business of something like, well, next it comes up, you have a look at the tailwind. So well, next comes back on the screen tomorrow morning after this now becomes a massively profitable company. It's bought. Sorry to focus on what I'm talking about. It becomes it becomes a massively profitable company now that it's bought um pain away. Um, you know, the sort of the second big is sort of the pain thing that you rub on yourself and makes everything go away. Yeah, massively profitable company.
3:59
Everything all merges together. You have a look at some of these shining stars in the small cap space like this one. And you see what the. Russell look at what the Russell did this morning. And it was Scotty Gray if you're watching as well though um it was the Russell looking at that all green across the entire board. You're going to see that maybe being the place where you'd want to be in the Russell. How much more are you going to stretch out of the seven? I don't know, I don't know how much more overweight you need to be in that seven. The other 93, though. I mean, there's a tailwind for the rest of the market, but I think that there's probably more of a tailwind in the small cap space and Aussie small caps as well, especially if you can see some some bright stars in there. Um, yeah. Is it time to mention maybe the well, next is going to be trading at 1.4 times 2025 earnings. We got him on Bell next. Um, I got the memo. What. It's my job. So you also provided us with a tweet. I think we can pull that up of a forward one. Merry Christmas. Yes. Pulling a bogged Tesla Cybertruck up a hill to get it out of trouble. So I hate those vehicles. So what is this telling us about, you know, the future of automated
4:59
driving? Uh, well, automated driving, I mean, have a look at the recall from Tesla this morning. That's effectively their entire fleet that has to go in. And that's because of the automated driving. Um, as much as I don't really trust it, but I don't really trust anything, people would also and studies have shown this, people would all rather make sure that people are driving their own cars, then automated vehicles, even if you show them facts in front of them, to say that automated driving is actually safer, people will absolutely never take take someone, let someone else or some other thing have control over their own destiny like that, because people are irrational beings. Tesla is not a stock that I'd want to be in. That Tesla Cybertruck I think is insane. I don't think Christmas and this is a bit more fun stuff, but I don't think Christmas could have come early enough for the Ford marketing team to have an absolute gift presented to them, like that of having the F-150 dragging a Tesla Cybertruck with a Christmas tree on its roof over the five, a Ford, I should say over five years. Yeah, yeah, so it's Ford. I do prefer that as much as I do like the internal combustion engines. I'm a much bigger, uh, prefer of
5:59
the hydrogen engine. Not for passengers, but we're going to see commercial and hydrogen being the place. We're probably. That's another one of those shining stars that you want to be a part of as well. Yeah. And just finally, I mean, we were talking earlier about AI and Alexa and Siri and you should always be nice to them. But you're saying even CBA now collecting data. That's a very interesting one as well. And I don't really know what to make of this, but I saw something pop up, uh, with, with CBA talking about that we're collecting. We are we are tracking your data as part of being able to, to generate an image of your carbon footprint as well. It seems very strange to to be able to we're collecting your transaction data so we can correlate your spending habits with carbon emissions data based on Australian averages. I'm not sure why they're doing this, but there is some reason as to it. It just sort of goes that, well, companies are making sure that that they are going on that green direction. I think maybe individuals want to make sure that they're going in that green direction. I don't know if the carbon footprint is really the direction that you want to be going on that one. There's some other places we should probably be pointing the finger
6:58
as opposed to myself, and how much I'm using my little MG.